Telluris Biotech India Profile
Key Indicators
- Authorised Capital ₹ 3.25 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.80 Cr
as on 23-10-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 118.53%
(FY 2023)
- Profit -73.22%
(FY 2023)
- Ebitda -76.93%
(FY 2023)
- Net Worth -54.44%
(FY 2023)
- Total Assets 20.03%
(FY 2023)
About Telluris Biotech India
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.25 Cr and a paid-up capital of Rs 2.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vijaya Raghavan, Arvind Modi, Bathina Sowmya, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100TG2015PTC101085
- Company No.
101085
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Oct 2015
- Date of AGM
30 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Telluris Biotech India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venu Polineni | Managing Director | 08-Oct-2015 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkateswarlu Bandi | Director | 09-Dec-2020 | Current |
Arvind Modi | Nominee Director | 09-Dec-2020 | Current |
Vijaya Raghavan | Director | 20-Sep-2019 | Current |
Bathina Sowmya | Whole-Time Director | 08-Oct-2015 | Current |
Financial Performance and Corporate Structure Insights of Telluris Biotech India.
Telluris Biotech India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 118.53% increase. The company also saw a substantial fall in profitability, with a 73.22% decrease in profit. The company's net worth observed a substantial decline by a decrease of 54.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Telluris Biotech India?
In 2023, Telluris Biotech India had a public holding of 1.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sathguru Catalyser Advisors Private LimitedActive 8 years 7 months
Vijaya Raghavan and Arvind Modi are mutual person
- Telluris Global Crop Science Private LimitedActive 2 years 6 months
Vijaya Raghavan, Arvind Modi and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Telluris Biotech India?
Telluris Biotech India has a workforce of 50 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Telluris Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Telluris Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.